Research.Patient.info

Primary Dilated Cardiomyopathy Due to Either MYH7 o TTN Variants research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic exploratory (Phase II)
AN OPEN-LABEL, EXPLORATORY STUDY OF THE SAFETY AND PRELIMINARY EFFICACY OF DANICAMTIV IN STABLE AMBULATORY PARTICIPANTS WITH PRIMARY DILATED CARDIOMYOPATHY DUE TO EITHER MYH7 OR TTN VARIANTS OR OTHER CAUSALITIES
This study looks at a new medicine called Danicamtiv for people with a specific heart condition called dilated cardiomyopathy. We want to see if it's safe and if it helps the heart work better. This is an early-stage study to learn more about the medicine.
Spain · Germany